Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin-resistant Subline of Human Colon Carcinoma

スポンサーリンク

概要

• 論文の詳細を見る
• 2000-05-31

著者

• Shiba T

  Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research

• Tsuruo T

  Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese

• Terui Shoji

  国立がんセンター中央病院

• Takahashi Shunji

  Cancer Inst. Hospital Tokyo Jpn

• Oh‐hara T

  Cancer Chemotherapy Center Japanese Foundation For Cancer Research

• Andoh Toshiwo

  Department Of Hygienic Chemistry Meiji College Of Pharmacy

• Andoh Toshiwo

  Department Of Bioengineering Faculty Of Engineering Soka University

• Tajiri T

  Department Of Surgery I Nippon Medical School

• TAKAYAMA Shin

  Department of Surgery

• TSUKAHARA Satomi

  Cancer Chemotherapy Center, Japanese Foundation for Cancer Research

• TSURUO Takashi

  Cancer Chemotherapy Center, Japanese Foundation for Cancer Research

• Tsuruo Takashi

  Division Of Molecular Oncology Aichi Cancer Center Research Institute

• SUGIMOTO Yoshikazu

  Cancer Chemotherapy Center, Japanese Foundation for Cancer Research

• Shiba Tadayoshi

  Department Of Molecular Biology Kitasato University

• OH-HARA Tomoko

  Cancer Chemotherapy Center, Japanese Foundation for Cancer Research

• Sugimoto Yoshikazu

  Division Of Chemotherapy Faculty Of Pharmacy Keio University

• Sugimoto Yoshikazu

  Division Of Gene Therapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research

• Oh-hara Tomoko

  Cancer Chemotherapy Center Japanese Foundation For Cancer Research

• Tsuruo Takashi

  The Cancer Chemotherapy Center Japanese Foundation For Cancer Research (jfcr)

• Tsuruo Takashi

  Cancer Chemotherapy Center

• Takahashi Shunji

  Department Of Oncology And Hematology Cancer Institute Hospital

• Tsuruo T

  Japanese Foundation For Cancer Research Tokyo Jpn

• Tsukahara Satomi

  Cancer Chemotherapy Center Japanese Foundation For Cancer Research

• YANASE Kae

  Cancer Chemotherapy Center Japanese Foundation for Cancer Research

• Tsukahara Satomi

  Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research

• Tsukahara Satomi

  Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research

• Sugimoto Yoshikazu

  Department Of Gene Therapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research

関連論文

• Cancer of Unknown Primary Site:A Review of 28 Cases and the Efficacy of Cisplatin/Docetaxel Therapy at a Single Institute in Japan
• Characterization of liver-cirrhosis nodules by analysis of gene-expression profiles and patterns of allelic loss
• Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
• Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
• Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells
• Increased incidence of interstitial pneumonia by CHOP combined with rituximab
• Functional MRI : Principles and Applications to the Visual System
• Identification of a 1-Mb Common Region at 16q24.1-24.2 Deleted in Hepatocellular Carcinoma
• Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
• Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
• PTEN/MMAC1 Mutations in Hepatocellular Carcinomas: Somatic Inactivation of Both Alleles in Tumors
• Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer : cross-resistance to capecitabine
• Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients
• Does Lapatinib, a Small-Molecule Tyrosine Kinase Inhibitor, Constitute a Breakthrough in the Treatment of Breast Cancer?
• Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
• High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
• Severe Infusion Reaction Induced by Trastuzumab : A Case Report
• Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer
• Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer
• Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
• Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers
• Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor B10 associated with prostate cancer
• Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case-control series
• High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
• Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab
• Gene Therapy for Breast Cancer.-Review of Clinical Gene Therapy Trials for Breast Cancer and MDR1 Gene Therapy Trial in Cancer Institute Hospital
• TUSC4/NPRL2, a novel PDK1-interacting protein, inhibits PDK1 tyrosine phosphorylation and its downstream signaling
• Involvement of mitochondrial aggregation in arsenic trioxide (As_2O_3)-induced apoptosis in human glioblastoma cells
• MOLECULAR TARGETING THERAPY OF CANCER : DRUG RESISTANCE, APOPTOSIS AND SURVIVAL SIGNAL
• Molecular targeting therapy of cancer : drug resistance, apoptosis and survival signal
• Sentinel Lymph Node Biopsy Using Tin Colloid RI and Blue Dye Method
• Correlation of Allelic Losses and Clinicopathological Factors in 504 Primary Breast Cancers
• Association of Allelic Losses at 3p25.1, 13q12, or 17p13.3 with Poor Prognosis in Breast Cancers with Lymph Node Metastasis
• Mitochondria regulate the unfolded protein response leading to cancer cell survival under glucose deprivation conditions
• Preventing the unfolded protein response via aberrant activation of 4E-binding protein 1 by versipelostatin
• Inhibition of Chromosome Separation in Fertilized Starfish Eggs by Kalihinol F, a Topoisomerase I Inhibitor Obtained from a Marine Sponge(Biochemistry & Molecular Biology)
• Surgery for Ductal Carcinoma in situ
• Tolerability and Safety of Classic Cyclophosphamide, Methotrexate, and Fluorouracil Treatment in Japanese Patients with Early Breast Cancer
• Clinical Study on the Metastasis to the Eyes from Breast Cancer
• Reviewing the definition of "elderly"
• Platelet aggregation in the formation of tumor metastasis
• A New Quinoline Derivative MS-209 Reverses Multidrug Resistance and Inhibits Multiorgan Metastases by P-glycoprotein-expressing Human Small Cell Lung Cancer Cells
• Report from the second Japanese Urological Association-Japanese Society of Medical Oncology joint conference, 2007 : 'Diagnosis and treatment of urological malignant tumors : How can we promote subspecialists?'
• Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women
• Association of a single-nucleotide polymorphism in the promoter region of leukemia inhibitory factor receptor gene with low bone mineral density in adult women
• Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women
• Association of natural tooth loss with genetic variation at the human matrix Gla protein locus in elderly women
• Association of the -381T/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss
• Thirteen single-nucleotide polymorphisms in the human osteopontin gene identified by sequencing of the entire gene in Japanese individuals
• Linkage disequilibrium and haplotype analysis among ten single-nucleotide polymorphisms of interleukin 11 identified by sequencing of the gene
• POTENTIATION OF CHEMOTHERAPEUTIC EFFECT OF VINCRISTINE IN VINCRISTINE RESISTANT TUMOR BEARING MICE BY CALMODULIN INHIBITOR CLOMIPRAMINE
• ANTITUMOR EFFICACIES OF ACLACINOMYCIN A BY ORAL ADMINISTRATION
• High-level Expression of P-glycoprotein and 85 kD Protein as Assessed by Flow Cytometry and Immunocytochemistry in Leukemias and Malignant Lymphomas
• Improved detection of axillary hot nodes in lymphoscintigraphy in breast cancer located in the upper lateral quadrant with additional projection imaging
• What is the Predictor for Invasion in Non-palpable Breast Cancer with Microcalcifications?
• Two Distinct Commonly Deleted Regions on Chromosome 13q Suggest Involvement of BRCA2 and Retinoblastoma Genes in Sporadic Breast Carcinomas
• A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density
• Linkage of interleukin 6 locus to human osteopenia by sibling pair analysis
• Association of bone mineral density with polymorphism of the human matrix Gla protein locus in elderly women
• Trends in the incidence of hip fracture in Japan,1987-1997:The third nationwide survey
• Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2
• Combination Therapy with Antibody and Interleukin-2 Gene Transfer against Multidrug-resistant Cancer Cells
• Transduction of the Macrophage Colony-stimulating Factor Gene into Human Multidrug Resistant Cancer Cells : Enhanced Therapeutic Efficacy of Monoclonal Anti-P-glycoprotein Antibody in Nude Mice
• Expression of Carbohydrate-Binding Protein p33/41 in Human Tumor Cell Lines
• Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer
• Oncogenic role of NALP7 in testicular seminomas
• Prospective study of combined treatment with interferon-alpha and active vitamin D_3 for Japanese patients with metastatic renal cell carcinoma
• Immunological Quantitation of DT-Diaphorase in Carcinoma Cell Lines and Clinical Colon Cancers : Advanced Tumors Express Greater Levels of DT-Diaphorase
• Acute Induction of Adriamycin-resistance in Human Colon Carcinoma HT-29 Cells Exposed to a Sublethal Dose of Adriamycin
• Novel single nucleotide polymorphisms of the human nuclear factor kappa-B 2 gene identified by sequencing the entire gene
• New Cdc25B Tyrosine Phosphatase Inhibitors, Nocardiones A and B, Produced by Nocardia sp. TP-A0248 : Taxonomy, Fermentation, Isolation, Structural Elucidation and Biological Properties
• Lipomatous Hypertrophy of the Interatrial Septum With Cutaneous Lipomatosis
• The polar neutral and basic taxoids isolated from needles and twigs of Taxus cuspidata and their biological activity
• A novel cinnamic acid derivative that inhibits Cdc25 dual-specificity phosphatase activity
• In vitro Antitumor Activity of TAS-103, a Novel Quinoline Derivative That Targets Topoisomerases I and II
• Inhibition of Tumor Cell Invasion and Matrix Degradation by Aminopeptidase Inhibitors
• A NOVEL ANTITUMOR CYCLIC HEXAPEPTIDE (RA-700) OBTAINED FROM RUBIAE RADIX
• Inhibitory Effect of ATF3 Antisense Oligonucleotide on Ectopic Growth of HT29 Human Colon Cancer Cells
• Analysis of Novel Metastasis-associated Gene TI-227
• Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export
• Acyl-CoA synthetase as a cancer survival factor : its inhibition enhances the efficacy of etoposide
• Leptosins isolated from marine fungus Leptoshaeria species inhibit DNA topoisomerases I and/or II and induce apoptosis by inactivation of Akt/protein kinase B
• Overexpression of the potential kinase serine/threonine/tyrosine kinase 1 (STYK 1) in castration-resistant prostate cancer
• Ribozymes targeting serine/threonine kinase Akt1 sensitize cells to anticancer drugs
• Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes
• Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenoposal Japanese women
• An easy and reproducible semi-automatic method for the evaluation of ^Tc-galactosyl human serum albumin
• Estrone and 17β-Estradiol Reverse Breast Cancer Resistance Protein-mediated Multidrug Resistance
• Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin-resistant Subline of Human Colon Carcinoma
• Recent advances in ideas on the molecular pathology and clinical aspects of Von Hippel-Lindau disease
• Inhibition by Differentiation-inducing Agents of Wild-type p53-dependent Apoptosis in HL-60 Cells
• Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
• 5αDH-DOC (5α-dihydro-deoxycorticosterone) activates androgen receptor in castration-resistant prostate cancer
• Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells
• BCRP/ABCG2 confers anticancer drug resistance without covalent dimerization
• REGULATION OF GENE EXPRESSION DURING REDIFFERENTIATION OF PROMYELOCYTIC LEUKEMIA CELLS HL-60 BY 12-O-TETRADECANOYLPHORBOL-13-ACETATE
• Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer
• Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients
• Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane
• Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors

もっと見る 閉じる

スポンサーリンク